Biotech

All Articles

ArsenalBio increases $325M, pivots off of former lead property

.Arsenal Biosciences is carrying on up. The tissue therapy company has actually added on $325 millio...

Lilly- backed weight reduction biotech data IPO

.After raising $170 thousand back in February, metabolic disease-focused BioAge Labs has actually su...

Aelis' cannabis make use of drug fails period 2b, steering Indivior to rethink $100M possibility

.Aelis Farma's chances of safeguarding a quick, positive choice on a $one hundred thousand option re...

ProKidney stops period 3 test not needed for tissue treatment approval

.ProKidney has actually ceased among a set of phase 3 trials for its tissue treatment for renal heal...

Vaxcyte surges on 'remarkable' 31-valent PCV succeed versus Pfizer

.Vaxcyte revealed what analysts named "spectacular" phase 1/2 information for its own 31-valent pneu...

Recursion's human brain ailment test presents insufficient documentation of efficacy

.Recursion has discovered with a very early exam of its own tech-enabled technique to medicine disco...

Acepodia, Pfizer click on together for chemistry-based cell therapy

.Contact it a case of good chemical make up: Acepodia, a biotech based upon Nobel Champion scientifi...

Praxis epilepsy medicine minimizes confiscations in period 2 litigation

.Praxis Accuracy Medicines has scored one more midphase gain in epilepsy this year, along with its o...

Three directors surrender as Dyne articles mixed data for DMD applicant

.After getting away a scientific hold a number of years back, Dyne Rehab has actually revealed brand...

Arrowhead fires off period 3 records in unusual metabolic health condition ahead of market clash with Ionis

.Arrowhead Pharmaceuticals has shown its own hand ahead of a potential showdown with Ionis, releasin...